Diphenhydramine and magnesium salicylate and Ranibizumab Intraocular
Determining the interaction of Diphenhydramine and magnesium salicylate and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diphenhydramine / magnesium salicylate
Brand name: Doans PM
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Diphenhydramine and magnesium salicylate-Ranibizumab ophthalmic
- Diphenhydramine and magnesium salicylate-Ranitidine
- Diphenhydramine and magnesium salicylate-Ranitidine Capsule
- Diphenhydramine and magnesium salicylate-Ranitidine Hydrochloride
- Diphenhydramine and magnesium salicylate-Ranitidine Injection
- Diphenhydramine and magnesium salicylate-Ranitidine Suspension
- Ranibizumab Intraocular-Diphenhydramine and phenylephrine
- Ranibizumab Intraocular-Diphenhydramine and Phenylephrine Liquid, Solution, and Syrup
- Ranibizumab Intraocular-Diphenhydramine and Phenylephrine Oral Strips
- Ranibizumab Intraocular-Diphenhydramine Capsules
- Ranibizumab Intraocular-Diphenhydramine Capsules and Tablets
- Ranibizumab Intraocular-Diphenhydramine Chewable Tablets and Orally-Disintegrating Tablets